OKYO Pharma Limited
OKYO
$1.61
$0.042.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.29M | -1.29M | -1.01M | -1.01M | -1.34M |
| Total Depreciation and Amortization | 400.00 | 400.00 | 700.00 | 700.00 | 600.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.25M | 1.25M | 628.20K | 628.20K | 4.90K |
| Change in Net Operating Assets | -722.20K | -722.20K | -400.40K | -400.40K | 1.21M |
| Cash from Operations | -764.20K | -764.20K | -784.80K | -784.80K | -120.70K |
| Capital Expenditure | -- | -- | -600.00 | -600.00 | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -600.00 | -600.00 | -- |
| Total Debt Issued | -- | -- | 474.10K | 474.10K | 900.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.16M | 2.16M | 577.90K | 577.90K | 275.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.16M | 2.16M | 1.05M | 1.05M | 275.90K |
| Foreign Exchange rate Adjustments | -64.70K | -64.70K | 20.30K | 20.30K | -75.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.33M | 1.33M | 286.90K | 286.90K | 80.20K |